No valuation for NuvOx Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($19.8M) and the funding record below are the closest available signals.
- ·The complete investor list: 19 names
- ·Watch NuvOx Therapeutics: the Monday email on marks, rounds and moves
NuvOx Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2023 | Debt | $1.1M | ▮ | ▮ |
Membership and data by Private Market View
How much has NuvOx Therapeutics raised?
NuvOx Therapeutics has raised $19.8 million in total; 1 of its rounds is on record. The largest on record was a $1.1 million debt round in Jan 2023.
NuvOx Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Nov 2024 ($235,000 sold to 4 investors).
How NuvOx Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For NuvOx Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about NuvOx Therapeutics
- How much has NuvOx Therapeutics raised?
- NuvOx Therapeutics has raised $19.8M in total funding across 1 recorded rounds.
- When did NuvOx Therapeutics last raise?
- NuvOx Therapeutics last raised in Jan 2023 (Debt), raising $1.1M.